WCM
OPNT

Wealthcare Capital Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Wealthcare Capital Management’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15
Closed – – 731
2021
Q1 		$0 Buy
+15
New +$171 ﹤0.01% 768

Other funds holding OPNT

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wealthcare Capital Management's OPNT Position: Q2 2021 in Review

Wealthcare Capital Management sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q2 2021, closing a stake of 15 shares.

Wealthcare Capital Management first reported a position in OPNT in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 26 funds tracked by Wall St. Rank hold OPNT as of Q2 2021.

  • Wealthcare Capital Management reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Capital Management sold 15 Opiant Pharmaceuticals, Inc. Common Stock shares in Q2 2021.
  • Wealthcare Capital Management first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Wealthcare Capital Management's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $0 in Q1 2021.
  • 26 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Wealthcare Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.